Horizon Pharma (HZNP) Wins IPR Ruling Upholding Patent on Ravicti Drug - Bloomberg
- Record-setting rally pushes on as S&P ends week up 3 percent
- Trump's Cohn Pick Most Bullish Sign Yet for Banks - Cowen
- Unusual 11 Mid-Day Movers: (IDXG) (INVN) (EBS) Higher; (SCON) (DTEA) (DLTH) Lower (more...)
- 21st Century Fox (FOXA) offers to acquire Sky for GBP10.75/share
- Coca Cola (KO) Announces James Quincey to Succeed Muhtar Kent as CEO; Kent to Continue as Chairman
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
Horizon Pharma (NASDAQ: HZNP) Wins IPR Ruling Upholding Patent on Ravicti Drug - Bloomberg
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- VirnetX Holding (VHC) Disappointed on Federal Circuit's Decisions; Positive on Dissenter
- Horizon Pharma (HZNP) Stock Could Plateau Today After Drop - Mizuho
- Basic Energy Services (BAS) Announces Court Approval Of Restructuring and Recap Plan
Create E-mail Alert Related CategoriesCorporate News, Litigation, Trader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!